ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NLSP) (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery ...
China SXT Pharmaceuticals announces a 1-for-8 share consolidation effective February 25, 2025, to comply with Nasdaq listing requirements. China SXT Pharmaceutics, Inc. announced a 1-for-8 share ...
NLS Pharmaceutics (NLSP) announced that it intends to effect a reverse share split of the company’s issued and outstanding common shares, par value CHF 0.03 per share, at a ratio of 1-for-10. The ...
TAIZHOU, China - China SXT Pharmaceutics, Inc. (NASDAQ:SXTC), a specialty pharmaceutical company focused on Traditional Chinese Medicine Pieces (TCMPs), announced it will implement a 1-for-150 share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results